SHA: 688520

Company Drug

Sinocelltech’s Ripertamab Wins NMPA Approval for DLBCL Treatment

Fineline Cube Aug 31, 2022

China-based Sinocelltech Group Ltd (SHA: 688520) has received New Drug Application (NDA) approval from the...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod